Ng C F, Chan L W, Wong K T, Cheng C W, Yu S C H, Wong W S
Division of Urology, Department of Surgery, Prince of Wales Hospital, Hong Kong, China.
Int Braz J Urol. 2004 Mar-Apr;30(2):102-7; discussion 108. doi: 10.1590/s1677-55382004000200003.
We investigate the use of non-contrast helical computerized tomography (NCHCT) in the measurement of differential renal parenchymal volume as a surrogate for differential creatinine clearance (CrCl) for unilateral chronically obstructed kidney.
Patients with unilateral chronically obstructed kidneys with normal contralateral kidneys were enrolled. Ultrasonography (USG) of the kidneys was first done with the cortical thickness of the site with the most renal substance in the upper pole, mid-kidney, and lower pole of both kidneys were measured, and the mean cortical thickness of each kidney was calculated. NCHCT was subsequently performed for each patient. The CT images were individually reviewed with the area of renal parenchyma measured for each kidney. Then the volume of the slices was summated to give the renal parenchymal volume of both the obstructed and normal kidneys. Finally, a percutaneous nephrostomy (PCN) was inserted to the obstructed kidney, and CrCl of both the obstructed kidney (PCN urine) and the normal side (voided urine) were measured two 2 after the relief of obstruction.
From March 1999 to February 2001, thirty patients were enrolled into the study. Ninety percent of them had ureteral calculi. The differential CrCl of the obstructed kidney (%CrCl) was defined as the percentage of CrCl of the obstructed kidney as of the total CrCl, measured 2 weeks after relief of obstruction. The differential renal parenchymal volume of the obstructed kidney (%CTvol) was the percentage of renal parenchymal volume as of the total parenchymal volume. The differential USG cortical thickness of the obstructed kidney (%USGcort) was the percentage of mean cortical thickness as of the total mean cortical thickness. The Pearson's correlation coefficient (r) between %CTvol and %CrCl and that between %USGcort and %CrCl were 0.756 and 0.543 respectively. The regression line was %CrCl = (1.00) x %CTvol - 14.27. The %CTvol overestimated the differential creatinine clearance by about 14%, but the correlation is good.
The differential renal parenchymal volume measured by NCHCT provided a reasonable prediction of differential creatinine clearance in chronically obstructed kidneys.
我们研究使用非增强螺旋计算机断层扫描(NCHCT)测量患侧慢性梗阻性肾病的肾实质体积差异,以此作为患侧肌酐清除率(CrCl)差异的替代指标。
纳入对侧肾脏正常的单侧慢性梗阻性肾病患者。首先对肾脏进行超声检查(USG),测量双侧肾脏上极、肾中部和下极肾实质最多处的皮质厚度,并计算每个肾脏的平均皮质厚度。随后对每位患者进行NCHCT检查。对CT图像进行单独分析,测量每个肾脏的肾实质面积。然后将各层面的体积相加,得出患侧和正常侧肾脏的肾实质体积。最后,对患侧肾脏进行经皮肾造瘘术(PCN),梗阻解除2周后测量患侧肾脏(PCN尿液)和正常侧(晨尿)的肌酐清除率。
1999年3月至2001年2月,30例患者纳入本研究。其中90%患有输尿管结石。患侧肾脏的肌酐清除率差异(%CrCl)定义为梗阻解除2周后,患侧肾脏肌酐清除率占总肌酐清除率的百分比。患侧肾脏的肾实质体积差异(%CTvol)是患侧肾实质体积占总肾实质体积中的百分比。患侧肾脏的超声皮质厚度差异(%USGcort)是患侧平均皮质厚度占总平均皮质厚度的百分比。%CTvol与%CrCl之间以及%USGcort与%CrCl之间的Pearson相关系数(r)分别为0.756和0.543。回归线为%CrCl = (1.00) × %CTvol - 14.27。%CTvol高估了肌酐清除率差异约14%,但相关性良好。
NCHCT测量的患侧肾脏肾实质体积差异可为慢性梗阻性肾病的肌酐清除率差异提供合理预测。